JP2024525665A5 - - Google Patents

Info

Publication number
JP2024525665A5
JP2024525665A5 JP2024501179A JP2024501179A JP2024525665A5 JP 2024525665 A5 JP2024525665 A5 JP 2024525665A5 JP 2024501179 A JP2024501179 A JP 2024501179A JP 2024501179 A JP2024501179 A JP 2024501179A JP 2024525665 A5 JP2024525665 A5 JP 2024525665A5
Authority
JP
Japan
Prior art keywords
sequence
prime
polynucleotide
composition according
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024501179A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525665A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/035613 external-priority patent/WO2023283092A1/en
Publication of JP2024525665A publication Critical patent/JP2024525665A/ja
Publication of JP2024525665A5 publication Critical patent/JP2024525665A5/ja
Pending legal-status Critical Current

Links

JP2024501179A 2021-07-06 2022-06-29 効率的なゲノム編集のための組成物及び方法 Pending JP2024525665A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163218744P 2021-07-06 2021-07-06
US63/218,744 2021-07-06
US202163219623P 2021-07-08 2021-07-08
US63/219,623 2021-07-08
PCT/US2022/035613 WO2023283092A1 (en) 2021-07-06 2022-06-29 Compositions and methods for efficient genome editing

Publications (2)

Publication Number Publication Date
JP2024525665A JP2024525665A (ja) 2024-07-12
JP2024525665A5 true JP2024525665A5 (cg-RX-API-DMAC10.html) 2025-07-07

Family

ID=84800962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501179A Pending JP2024525665A (ja) 2021-07-06 2022-06-29 効率的なゲノム編集のための組成物及び方法

Country Status (6)

Country Link
US (1) US20240228988A1 (cg-RX-API-DMAC10.html)
EP (1) EP4367227A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024525665A (cg-RX-API-DMAC10.html)
AU (1) AU2022306377A1 (cg-RX-API-DMAC10.html)
CA (1) CA3224970A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023283092A1 (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
IL296095A (en) 2020-03-04 2022-11-01 Flagship Pioneering Innovations Vi Llc Improved methods and compositions for genome modulation
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
KR20260037664A (ko) 2021-09-08 2026-03-18 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 게놈을 조절하기 위한 방법 및 조성물
CA3231712A1 (en) 2021-09-08 2023-03-16 Flagship Pioneering Innovations Vi, Llc Pah-modulating compositions and methods
WO2023039586A1 (en) * 2021-09-10 2023-03-16 Agilent Technologies, Inc. Guide rnas with chemical modification for prime editing
EP4444362A4 (en) 2021-12-10 2026-04-01 Flagship Pioneering Innovations Vi Llc CFTR COMPOSITIONS AND MODULATION METHODS
WO2023225670A2 (en) 2022-05-20 2023-11-23 Tome Biosciences, Inc. Ex vivo programmable gene insertion
WO2024020587A2 (en) 2022-07-22 2024-01-25 Tome Biosciences, Inc. Pleiopluripotent stem cell programmable gene insertion
WO2024170778A1 (en) 2023-02-17 2024-08-22 Anjarium Biosciences Ag Methods of making dna molecules and compositions and uses thereof
WO2024178144A1 (en) * 2023-02-22 2024-08-29 Prime Medicine, Inc. Methods and compositions for editing nucleotide sequences
CN117511906A (zh) * 2023-03-14 2024-02-06 中国农业大学 一种高效的Csy4核酸酶切割介导的多基因引导编辑系统CMPE及相关蛋白
WO2024249584A2 (en) * 2023-05-31 2024-12-05 University Of Massachusetts Improved modular prime editing with modified effectors and templates
WO2024259051A1 (en) * 2023-06-14 2024-12-19 The Children's Medical Center Corporation Systems and methods for modifying a polynucleotide
WO2025038881A1 (en) * 2023-08-16 2025-02-20 Beam Therapeutics Inc. Prime editing of single base mutations in sickle cell disease
WO2025076306A1 (en) * 2023-10-06 2025-04-10 University Of Massachusetts Prime editors having improved prime editing efficiency
WO2025194133A1 (en) 2024-03-15 2025-09-18 Beam Therapeutics Inc. Prime editing of single base mutations in alpha-1 antitrypsin deficiency
WO2025226946A1 (en) * 2024-04-24 2025-10-30 Cedric Francois Methods and compositions for the treatment of androgenic alopecia
WO2025231071A1 (en) * 2024-05-01 2025-11-06 Beam Therapeutics Inc. Compositions and methods for cell conditioning

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201720948D0 (en) * 2017-12-15 2018-01-31 Autolus Ltd Plasmid system
US11339385B2 (en) * 2018-03-25 2022-05-24 GeneTether, Inc. Modified nucleic acid editing systems for tethering donor DNA
WO2020033083A1 (en) * 2018-08-10 2020-02-13 Cornell University Optimized base editors enable efficient editing in cells, organoids and mice
JP7646552B2 (ja) * 2019-01-31 2025-03-17 ビーム セラピューティクス インク. 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ
JP7518549B2 (ja) * 2019-02-02 2024-07-18 シャンハイテック ユニバーシティ 遺伝子編集における非意図的な変異の阻害
WO2020191241A1 (en) * 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2021042047A1 (en) * 2019-08-30 2021-03-04 The General Hospital Corporation C-to-g transversion dna base editors
US20230051661A1 (en) * 2019-12-26 2023-02-16 Agency For Science, Technology And Research Nucleobase Editors

Similar Documents

Publication Publication Date Title
JP2023553935A5 (cg-RX-API-DMAC10.html)
AU736707B2 (en) Trimerising module
JP2024534523A5 (cg-RX-API-DMAC10.html)
JP2002503459A (ja) 繊維置換タンパク質を含有する修飾されたアデノウィルス
JP2024533311A5 (cg-RX-API-DMAC10.html)
JP2002503459A5 (cg-RX-API-DMAC10.html)
JPS62501470A (ja) 腫瘍壊死因子の精製、製造および使用法
JPS60252496A (ja) 新規なヒト生理活性ポリペプチド
JP2023534924A5 (cg-RX-API-DMAC10.html)
WO2022192754A2 (en) Methods of treating myotonic dystrophy type 1 using peptide-oligonucleotide conjugates
JP2024542995A5 (cg-RX-API-DMAC10.html)
JP2024511131A5 (cg-RX-API-DMAC10.html)
US5854025A (en) IGF-II analogues
JPH0866194A (ja) ヒト腫瘍壊死因子ミューテインをコードする遺伝子
JP7736329B2 (ja) Dux4遺伝子を標的とした顔面肩甲上腕型筋ジストロフィーの治療方法
US7981446B2 (en) Pharmaceutical compositions and methods for delivering nucleic acids into cells
Kato et al. Molecular cloning and expression of mouse Mg2+-dependent protein phosphatase β-4 (type 2Cβ-4)
JP2024533314A5 (cg-RX-API-DMAC10.html)
JP2024528967A5 (cg-RX-API-DMAC10.html)
WO1999062925A1 (en) Angiopoietin related gene sequence scarface 1
JP3455785B2 (ja) ヒト肝癌細胞由来増殖因子の遺伝子
JP7341451B2 (ja) タンパク質性化合物とその利用
Christie et al. A functional hybrid ribosome binding site in tryptophan operon messenger RNA of Escherichia coli
EP4520767A1 (en) Peptide kinase inhibitors and methods of use thereof
JP2946019B2 (ja) hTFIIIA遺伝子